Nordic Life Science 1
54 Barbro Ehnbom, the Founder and Chairman of SAL
SS The companies in attendance also benefited from a range of expertise including advice from Ann Rose, CEO and President, Regulatory for ViCro, a medical products company, on how to approach the FDA, and from Helén Waxberg, partner with the law firm Mannheimer Swartling, providing a legal roadmap on how to enter the US market and engage with the FDA. US Rep Diana DeGette (D-CO) shared insights into the Affordable Care Act. Maria Tufvesson Shuck, Partner, Mannheimer Swartling, and her colleagues provided a legal roadmap on how to enter the US market A select number of Swedish companies were invited to make presentations for the investors and other gathered. These were Affibody, Elypta, Cellink, BioArctic, Immunicum and Ziccum. For Ehnbom and Santesson, the 2019 conference achieved their aims of bringing Swedish life science to the attention of American investors. investors are starting to realize there are a lot of business opportunities they are missing out on because they are not looking at these smaller companies from Sweden,” Santesson said. “We need to find ways to enhance their interest and shift their attitudes. Obviously, the US is a huge market, with a totally different dimension of capital and a different way of doing business but there’s no reason why our Swedish companies can’t compete with the best.” NLS PHOTO COURTESY OF THE SWEDISH-AMERICAN LIFE SCIENCE SUMMIT